Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases

Osteoarthritis and Cartilage

Volumn 17, Issue 4, 2009, Pages 497-506

  Struglics, A ^a   Larsson, S ^a   Hansson, M ^a   Lohmander, L S ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Aggrecan; Aggrecanase; Proteolytic fragments; Synovial fluid; Western blot

Indexed keywords

AGGRECAN; ANTIBODY; BIOLOGICAL MARKER; AGGRECANASE; PROTEINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMAGE ANALYSIS; KNEE INJURY; KNEE OSTEOARTHRITIS; LUMINESCENCE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SYNOVIAL FLUID; WESTERN BLOTTING; KNEE; METABOLISM; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADULT; AGED; AGGRECANS; BLOTTING, WESTERN; ENDOPEPTIDASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KNEE INJURIES; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SYNOVIAL FLUID; YOUNG ADULT;

EID: 61549089342     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.09.017     Document Type: Article

References (45)

1. Lohmander L.S., Dahlberg L., Ryd L., and Heinegard D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 32 (1989) 1434-1442
2. Lohmander L.S., Hoerrner L.A., Dahlberg L., Roos H., Bjornsson S., and Lark M.W. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury. J Rheumatol 20 (1993) 1362-1368
3. Saxne T., Glennas A., Kvien T.K., Melby K., and Heinegard D. Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis. Arthritis Rheum 36 (1993) 20-25
4. Hou W.S., Li Z., Buttner F.H., Bartnik E., and Bromme D. Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation. Biol Chem 384 (2003) 891-897
5. Handley C.J., Mok M.T., Ilic M.Z., Adcocks C., Buttle D.J., and Robinson H.C. Cathepsin D cleaves aggrecan at unique sites within the interglobular domain and chondroitin sulfate attachment regions that are also cleaved when cartilage is maintained at acid pH. Matrix Biol 20 (2001) 543-553
6. Mort J.S., Magny M.C., and Lee E.R. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope. Biochem J 335 Pt 3 (1998) 491-494
7. Maehara H., Suzuki K., Sasaki T., Oshita H., Wada E., Inoue T., et al. G1-G2 aggrecan product that can be generated by M-calpain on truncation at Ala709-Ala710 is present abundantly in human articular cartilage. J Biochem 141 (2007) 469-477
8. Oshita H., Sandy J.D., Suzuki K., Akaike A., Bai Y., Sasaki T., et al. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain. Biochem J 382 (2004) 253-259
9. Sandy J.D. Proteolytic Degradation of Normal and Osteoarthritic Cartilage Matrix. In: Brandt K.D., Doherty M., and Lohmander L.S. (Eds). Osteoarthritis (2003), Oxford University Press, Oxford 82-92
10. Sandy J.D., Flannery C.R., Neame P.J., and Lohmander L.S. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 89 (1992) 1512-1516
11. Lohmander L.S., Neame P.J., and Sandy J.D. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 36 (1993) 1214-1222
12. Tortorella M.D., Pratta M., Liu R.Q., Austin J., Ross O.H., Abbaszade I., et al. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem 275 (2000) 18566-18573
13. Tortorella M.D., Liu R.Q., Burn T., Newton R.C., and Arner E. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 21 (2002) 499-511
14. Bonassar L.J., Frank E.H., Murray J.C., Paguio C.G., Moore V.L., Lark M.W., et al. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum 38 (1995) 173-183
15. Flannery C.R., Lark M.W., and Sandy J.D. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem 267 (1992) 1008-1014
16. Fosang A.J., Last K., Knauper V., Neame P.J., Murphy G., Hardingham T.E., et al. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J 295 Pt 1 (1993) 273-276
17. Fosang A.J., Last K., Knauper V., Murphy G., and Neame P.J. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380 (1996) 17-20
18. Lark M.W., Bayne E.K., Flanagan J., Harper C.F., Hoerrner L.A., Hutchinson N.I., et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 100 (1997) 93-106
19. Struglics A., Larsson S., Pratta M.A., Kumar S., Lark M.W., and Lohmander L.S. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthr Cartil 14 (2006) 101-113
20. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434 (2005) 644-648
21. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434 (2005) 648-652
22. East C.J., Stanton H., Golub S.B., Rogerson F.M., and Fosang A.J. ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecan. J Biol Chem 282 (2007) 8632-8640
23. Little C.B., Meeker C.T., Golub S.B., Lawlor K.E., Farmer P.J., Smith S.M., et al. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest 117 (2007) 1627-1636
24. Sumer E.U., Sondergaard B.C., Rousseau J.C., Delmas P.D., Fosang A.J., Karsdal M.A., et al. MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays. Osteoarthr Cartil 15 (2007) 212-221
25. Naito S., Shiomi T., Okada A., Kimura T., Chijiiwa M., Fujita Y., et al. Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage. Pathol Int 57 (2007) 703-711
26. Powell A.J., Little C.B., and Hughes C.E. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system. Arthritis Rheum 56 (2007) 3010-3019
27. Tortorella M.D., Burn T.C., Pratta M.A., Abbaszade I., Hollis J.M., Liu R., et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284 (1999) 1664-1666
28. Pratta M.A., Su J.L., Leesnitzer M.A., Struglics A., Larsson S., Lohmander L.S., et al. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments. Osteoarthr Cartil 14 (2006) 702-713
29. Struglics A., Larsson S., and Lohmander L.S. Estimation of the identity of proteolytic aggrecan fragments using PAGE migration and Western immunoblot. Osteoarthr Cartil 14 (2006) 898-905
30. Sandy J.D., and Verscharen C. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Biochem J 358 (2001) 615-626
31. Lohmander L.S., Ionescu M., Jugessur H., and Poole A.R. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum 42 (1999) 534-544
32. Moller H.J., Larsen F.S., Ingemann-Hansen T., and Poulsen J.H. ELISA for the core protein of the cartilage large aggregating proteoglycan, aggrecan: comparison with the concentrations of immunogenic keratan sulphate in synovial fluid, serum and urine. Clin Chim Acta 225 (1994) 43-55
33. Fosang A.J., Last K., and Maciewicz R.A. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J Clin Invest 98 (1996) 2292-2299
34. Will H., Dettloff M., Bendzko P., and Sveshnikov P. A quantitative assay for aggrecanase activity. J Biomol Tech 16 (2005) 459-472
35. Carter Q.L., Dotzlaf J., Swearingen C., Brittain I., Chambers M., Duffin K., et al. Development and characterization of a novel ELISA based assay for the quantitation of sub-nanomolar levels of neoepitope exposed NITEGE-containing aggrecan fragments. J Immunol Methods 328 (2007) 162-168
36. Little C.B., Hughes C.E., Curtis C.L., Janusz M.J., Bohne R., Wang-Weigand S., et al. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol 21 (2002) 271-288
37. Malfait A.M., Liu R.Q., Ijiri K., Komiya S., and Tortorella M.D. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 277 (2002) 22201-22208
38. Lohmander L.S., Hoerrner L.A., and Lark M.W. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 36 (1993) 181-189
39. McAlinden A., Dudhia J., Bolton M.C., Lorenzo P., Heinegard D., and Bayliss M.T. Age-related changes in the synthesis and mRNA expression of decorin and aggrecan in human meniscus and articular cartilage. Osteoarthr Cartil 9 (2001) 33-41
40. Valiyaveettil M., Mort J.S., and McDevitt C.A. The concentration, gene expression, and spatial distribution of aggrecan in canine articular cartilage, meniscus, and anterior and posterior cruciate ligaments: a new molecular distinction between hyaline cartilage and fibrocartilage in the knee joint. Connect Tissue Res 46 (2005) 83-91
41. Verdonk P.C., Forsyth R.G., Wang J., Almqvist K.F., Verdonk R., Veys E.M., et al. Characterisation of human knee meniscus cell phenotype. Osteoarthr Cartil 13 (2005) 548-560
42. Ilic M.Z., Vankemmelbeke M.N., Holen I., Buttle D.J., Clem Robinson H., and Handley C.J. Bovine joint capsule and fibroblasts derived from joint capsule express aggrecanase activity. Matrix Biol 19 (2000) 257-265
43. Vankemmelbeke M.N., Ilic M.Z., Handley C.J., Knight C.G., and Buttle D.J. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "aggrecanase" activity. Biochem Biophys Res Commun 255 (1999) 686-691
44. Lohmander L.S., and Eyre D.R. Biochemical markers as surrogate end points of joint disease. In: Reid D.M., and Miller C.G. (Eds). Clinical Trials in Rheumatoid Arthritis and Osteoarthritis (2008), Springer 249-274
45. Dahlberg L., Ryd L., Heinegard D., and Lohmander L.S. Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand 63 (1992) 417-423